For Release at
Interim Results for the six months ended
On track to deliver good growth
Summary Results
|
|
Half Year to 30th September |
% |
|
|
|
2006 |
2005 |
change |
|
Revenue Sales excluding precious metals Operating profit Profit before tax Total earnings per share Dividend per share |
£3,012m £744m £126.8m £115.1m 38.3p 9.9p |
£2,283m £637m £114.5m £106.4m 35.2p 9.1p |
+32 +17 +11 +8 +9 +9 |
·
Sales revenue up 32% reflecting good underlying volume
growth and higher precious metal prices
·
Operating profit up 11% with most of the growth
generated by Catalysts and Precious Metal Products Divisions
·
Profit before tax up 8% at £115.1 million
·
Total earnings per share up 9% at 38.3 pence. Interim
dividend increased in line with earnings growth to 9.9 pence
Divisional
Performance
Operating
Profit
|
|
Half Year
to 30th September |
% |
|
|
£m |
2006 |
2005 |
change |
|
Catalysts |
70.8 |
65.2 |
+9 |
|
Precious Metal Products |
37.2 |
30.6 |
+22 |
|
Pharmaceutical Materials |
17.0 |
16.2 |
+5 |
|
Ceramics |
10.2 |
10.8 |
-6 |
|
Corporate |
(8.4) |
(8.3) |
|
|
Operating profit |
126.8 ) |
114.5 ) |
+11 |
·
Catalysts Division’s profit growth reflects increased
sales of catalysed soot filters (CSFs) for diesel cars in
·
Precious Metal Products Division has benefited from
buoyant prices for platinum group metals and good growth in its manufacturing
businesses
Business
Prospects
·
Environmental Catalysts and Technologies (ECT) should
achieve double digit growth in sales and profits this year with additional
revenue from sales of heavy duty diesel (HDD) catalysts in the second half
·
Pre-buying of trucks ahead of the introduction of the
new emission standards will limit catalyst sales in 2006/07 but create further
growth as truck sales recover in 2007/08 and 2008/09
·
Additional investment is planned to expand capacity in
ECT and to provide increased working capital to support the emergence of the
new diesel catalyst markets
·
High oil price supports growth in Process Catalysts
and Technologies with increased demand for catalysts for synthesis gas
production and good prospects for Davy Process Technology
·
Precious Metal Products Division should continue to
benefit from favourable market conditions for platinum group metals and growth
in its manufacturing businesses
·
Pharmaceutical Materials Division’s recovery is
expected to continue in the second half of the year with stronger sales in the
·
Ceramics Division’s performance in the second half is
likely to be below last year but the division should remain highly cash generative
Commenting
on the results, Neil Carson, Chief Executive of Johnson Matthey said:
“Johnson Matthey has achieved good growth in the first half of 2006/07
with sales, excluding precious metals, up 17% and an 11% increase in operating
profit.
The outlook for the second half is for continued top-line growth, driven
by additional sales of emission control products for trucks and buses following
the introduction of the new heavy duty diesel emission standards in
Enquiries:
|
Ian Godwin |
Director, IR and Corporate Communications |
020 7269 8410 |
|
John Sheldrick |
Group Finance
Director |
020 7269 8408 |
|
Howard Lee |
The HeadLand
Consultancy |
020 7367 5225 |
|
Laura Hickman |
The HeadLand
Consultancy |
020 7367 5227 |
|
|
|
|
Report to Shareholders
Introduction
Johnson Matthey
performed well in the first half of 2006/07 with good growth in sales and
operating profit. Catalysts Division and
Precious Metal Products Division generated most of the growth. Sales were boosted by a significant rise in
the prices of platinum group metals with platinum averaging just over $1,200
per ounce (37% up on the first half of last year). Demand for catalysts was also strong with
expanding sales of catalysed soot filters, good autocatalyst demand in
The outlook for the
group for the second half remains encouraging, with further growth generated by
the new market for heavy duty diesel catalysts.
Review of Results
Revenue rose by 32%
in the half year to £3,012 million, partly as a result of higher prices for
platinum, palladium and rhodium. Sales
excluding the value of precious metals rose by 17%, reflecting good underlying
volume growth and increased non precious metal material costs, some of which
are a pass through for Johnson Matthey.
Operating profit
increased by 11% to £126.8 million.
Exchange translation was slightly adverse, reducing profits by £0.8
million compared with the first half of last year. Interest rose by £4.5 million as a result of
higher average borrowings and an increase in short term interest rates,
particularly in the
Total earnings per
share (eps) increased by 9% to 38.3 pence.
The growth rate in eps was slightly stronger than growth in profit
before tax mainly as a result of the accretive effect of share buy-backs.
Dividend
The interim
dividend has been increased by 9% to 9.9 pence, in line with the growth in
earnings per share.
Operations
Catalysts Division’s sales grew
by 48% to £996 million, boosted by significantly higher prices for platinum,
palladium and rhodium. Excluding the
value of precious metals, sales increased by 22% to £458 million. This increase was driven by good volume
growth and the impact of higher material costs, particularly the cost of
substrates for catalysed soot filters (CSFs), which is a pass through for
Johnson Matthey.
The division’s
operating profit rose by 9% to £70.8 million, despite a weaker US dollar
exchange rate. Translated at last year’s
exchange rates operating profit would have been 10% up.
Environmental Catalysts and Technologies (ECT) had a good first half with sales and operating profit well ahead of
last year. The division achieved strong
growth in
ECT’s growth was
achieved despite a relatively weak global car market. In the six month period to
Estimated Light
Vehicle Sales and Production
|
|
|
Half year to 30th
September |
|
|
|
|
|
2006 millions |
2005 millions |
change % |
|
Global |
Sales Production Sales Production Sales Production Sales Production |
10.2 7.5 9.2 9.2 7.6 11.9 32.1 32.0 |
10.7 7.8 9.3 9.3 7.2 10.9 32.1 31.5 |
-4.7 -3.8 -1.1 -1.1 +5.6 +9.2 - +1.6 |
|
Source:
Global Insight |
|
|
|
|
We are seeing
increasing demand from many of the leading car companies in
Autocatalyst sales
have grown strongly in
The first half of
this year included some sales of heavy duty diesel catalysts in
Process Catalysts and Technologies (PCT) delivered good growth in sales and profits in the half year. The Ammonia, Methanol, Oil and Gas (AMOG)
business was well ahead of last year with continued strong demand for catalysts
and purification materials for industries where hydrogen or synthesis gas are
key intermediates. Our Catalysts &
Chemicals business performed well with increased sales of sponge nickel
catalysts. Sales of catalysts into the
pharmaceutical and fine chemicals sector also continued to grow.
Research Chemicals
benefited from the contribution from its new joint venture in
Davy Process Technology
(DPT), which was acquired in February 2006, performed well in the first six
months. DPT develops and licenses
chemical process technologies and successfully concluded two major contracts in
the first half of 2006/07. Tracerco,
PCT’s oil services business, acquired the process diagnostics business of Quest
TruTec in April 2006 for £3.8 million which has expanded Tracerco’s coverage
principally in the
Our Fuel Cells business achieved strong
growth in sales, from a small base, with significantly increased orders for
membrane electrode assemblies for direct methanol fuel cells (DMFCs). Most of these sales were for portable fuel
cells which are sold to European consumers.
We are continuing to work with a number of major electronics companies
who are developing small DMFC units for use in mobile phone chargers and laptop
computers.
Precious Metal Products Division’s sales rose by 27% to £1,861 million boosted by significantly higher
prices for platinum group metals (pgms).
Operating profit increased by 22% to £37.2 million with good growth in
both its marketing & distribution business and its manufacturing
operations.
The platinum
marketing & distribution business achieved good profit growth with good
demand for platinum and higher pgm prices.
Demand for platinum is expected to show a rise of 5% for calendar
2006. Tightening emissions legislation
and growing production of diesel vehicles has increased demand for
autocatalysts, outweighing a fall in demand for jewellery manufacturing caused
by the rising price. The average price
of platinum in the first half of Johnson Matthey’s financial year rose to
$1,206 per ounce, up 37% compared to the same period last year.
The price of
palladium rose significantly in the same period, up 78% to $337 per ounce,
supported by significant purchasing by investment funds. However, industrial demand for palladium is
expected to fall by 6% in calendar 2006.
Increasing autocatalyst consumption is being
outweighed by a reduction in demand from jewellery manufacturers in
The price of
rhodium has also moved sharply higher, more than doubling in comparison with
the same period last year to average $4,853 per ounce. Strong demand from the automobile market
coupled with interest from speculators contributed to the increase in what is
traditionally a tight and often volatile market.
The division’s pgm
fabrication business, Noble Metals, achieved good growth in the half year with
most of the growth coming in the
Pharmaceutical Materials Division’s sales rose by 13% to £65 million.
Operating profit grew by 5% to £17.0 million. Most of the growth came in the division’s
The recovery in the
The outlook for
sales of controlled drug APIs has also improved with the announcement by Barr
Pharmaceuticals, Inc. of its purchase from Shire plc of ADDERALL® (an immediate
release product used in the treatment of Attention Deficit Hyperactivity
Disorder). Johnson Matthey has an
exclusive agreement to supply the API to Barr for this product and already
supplies the API used in Barr’s existing generic version. The division will generate additional income
from sales of the branded product in the second half of this year. In addition, Barr has reached agreement with
Shire to launch its generic version of ADDERALL XR® (an extended release
product) in April 2009. Johnson Matthey
will also supply the API for this product which could generate significant
additional revenue at that time.
The division’s
European businesses’ profits were slightly ahead of last year with good sales
of specialist opiates offsetting weaker sales of bulk opiates, particularly
codeine. Sales of bulk opiates are
expected to recover in the second half of the year which should improve the
overall growth rate.
Ceramics Division’s sales were
unchanged from last year at £90 million.
Operating profit was 6% lower at £10.2 million.
Margins weakened a
little in the first half of 2006/07 and the division gave back some of the
gains it had made last year when both sales and profits were well ahead. Energy costs increased significantly,
particularly in
Finance
Exchange Rates
The main impact of
exchange rates on the group’s results comes from the translation of foreign
subsidiaries’ profits into sterling. The
group’s largest overseas investment is in the
Interest
In the six months
to
Taxation
The group’s tax
charge rose by £2.4 million to £33.5 million reflecting the higher profits made
in the period. The average rate was very
similar to the first half of last year at 29.1%. Tax paid of £41.9 million was greater than
tax payable following a below average payment in the second half of last
year. In the first half of last year the
group had a cash inflow on tax reflecting the benefit of a favourable
settlement with the UK Revenue.
Cash Flow
In the six months
to
Working capital
increased by £73.0 million in the period.
The biggest factor in this rise was significantly higher precious metal
prices which impacted both inventories and receivables. Physical metal stocks were actually lower
than on
The cash outflow on capital expenditure in the half year was £56.0
million which was 1.5 times depreciation.
We are planning to spend more on capital expenditure in the second half
with most of the investment in Catalysts Division. For the year as a whole we expect to spend at
a rate of 1.6 times depreciation with most of the investment in new capacity to
meet expected volume growth. Major
projects include: expansion of our diesel products factory at Royston, UK;
completion of the investment at our new factory in Philadelphia, USA to make
similar products for the US market; construction of our new autocatalyst
factories in South Korea and the Russian Federation; and additional production
facilities for AMOG.